BEAM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $9,660,529.49

Beam Therapeutics Insider Trading History Chart

Beam Therapeutics Share Price & Price History

^$24.23

▼ -0.83 (-3.31%)

As of 03/14/2025 05:00 PM ET

Days: 30 | 90 | 365

Beam Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
1/30/2025	John M Evans	CEO	Sell	30,000	$26.75	$802,500.00	908,659
1/2/2025	Christine Bellon	Insider	Sell	1,241	$24.68	$30,627.88	102,968
11/6/2024	Giuseppe Ciaramella	President	Sell	51,110	$26.36	$1,347,259.60	109,150
10/14/2024	Giuseppe Ciaramella	President	Sell	51,110	$26.27	$1,342,659.70	160,260
10/1/2024	Bethany J Cavanagh	SVP	Sell	289	$23.48	$6,785.72	44,931
10/1/2024	Christine Bellon	Insider	Sell	385	$23.48	$9,039.80	104,209
9/30/2024	John M Evans	CEO	Sell	60,000	$24.60	$1,476,000.00	938,659
7/1/2024	Amy Simon	Insider	Sell	502	$23.76	$11,927.52	69,553
6/27/2024	John M Evans	CEO	Sell	60,000	$24.50	$1,470,000.00	998,343
4/1/2024	Amy Simon	Insider	Sell	7,157	$32.13	$229,954.41	86,590
4/1/2024	Giuseppe Ciaramella	President	Sell	4,534	$32.12	$145,632.08	169,616
4/1/2024	John M Evans	CEO	Sell	18,102	$32.13	$581,617.26	1,058,343
4/1/2024	Terry-Ann Burrell	CFO	Sell	5,446	$32.12	$174,925.52	70,137
3/28/2024	John M Evans	CEO	Sell	60,000	$33.86	$2,031,600.00	998,262
2/13/2024	Fmr Llc	Insider	Sell	1,565	$30.76	$48,139.40	2,771,913
1/31/2024	John M Evans	CEO	Sell	60,000	$25.33	$1,519,800.00	1,058,262
1/3/2024	Christine Bellon	Insider	Sell	1,907	$26.42	$50,382.94	80,495
10/30/2023	Amy Simon	Insider	Sell	3,448	$18.70	$64,477.60	65,469
10/2/2023	Christine Bellon	Insider	Sell	388	$22.85	$8,865.80	82,402
7/24/2023	Giuseppe Ciaramella	Insider	Sell	1,206	$32.01	$38,604.06	48,250
7/21/2023	Giuseppe Ciaramella	Insider	Sell	155,324	$32.06	$4,979,687.44	48,250
7/10/2023	Amy Simon	Insider	Sell	391	$30.48	$11,917.68	68,917
4/3/2023	Giuseppe Ciaramella	Insider	Sell	1,918	$30.31	$58,134.58	114,044
4/3/2023	John M Evans	CEO	Sell	5,161	$30.31	$156,429.91	1,124,472
4/3/2023	Terry-Ann Burrell	CFO	Sell	2,454	$30.31	$74,380.74	49,303
1/26/2023	Terry-Ann Burrell	CFO	Sell	1,102	$45.16	$49,766.32	31,277
1/24/2023	Terry-Ann Burrell	CFO	Sell	14,810	$45.01	$666,598.10	31,277
1/18/2023	Terry-Ann Burrell	CFO	Sell	47,195	$45.14	$2,130,382.30	31,277
12/12/2022	Giuseppe Ciaramella	Insider	Sell	51,015	$42.70	$2,178,340.50	91,462
10/31/2022	John M Evans	CEO	Sell	30,000	$46.31	$1,389,300.00	1,058,520
8/5/2022	Fmr Llc	Insider	Sell	20,326	$60.50	$1,229,723.00
7/28/2022	John M Evans	CEO	Sell	30,000	$65.75	$1,972,500.00	1,088,520
4/28/2022	John M Evans	CEO	Sell	30,000	$37.98	$1,139,400.00	1,118,520
4/13/2022	Fmr Llc	Insider	Sell	19,466	$50.41	$981,281.06
3/31/2022	Giuseppe Ciaramella	Insider	Sell	1,859	$59.11	$109,885.49	115,614
3/31/2022	John M Evans	CEO	Sell	6,261	$59.11	$370,087.71	1,089,070
3/31/2022	Terry-Ann Burrell	CFO	Sell	1,787	$59.11	$105,629.57	38,278

See Full Table

SEC Filings (Institutional Ownership Changes) for Beam Therapeutics (NASDAQ:BEAM)

99.68% of Beam Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Beam Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
2/25/2025	Polar Asset Management Partners Inc.	208,255	$5.17M	0.1%	+901.2%	0.251%
2/19/2025	GF Fund Management CO. LTD.	1,739	$43K	0.0%	N/A	0.002%
2/17/2025	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	395,920	$9.82M	0.0%	-1.3%	0.478%
2/17/2025	Voloridge Investment Management LLC	413,409	$10.25M	0.0%	-10.8%	0.499%
2/17/2025	Woodline Partners LP	282,120	$7M	0.0%	N/A	0.341%
2/17/2025	Squarepoint Ops LLC	155,278	$3.85M	0.0%	N/A	0.188%
2/17/2025	Twinbeech Capital LP	127,664	$3.17M	0.1%	+119.3%	0.154%
2/17/2025	Two Sigma Advisers LP	19,000	$0.47M	0.0%	+77.6%	0.023%
2/17/2025	Two Sigma Investments LP	117,088	$2.90M	0.0%	+75.2%	0.141%
2/17/2025	State of Wyoming	9,049	$0.22M	0.0%	+120.0%	0.011%
2/17/2025	Tang Capital Management LLC	50,000	$1.24M	0.1%	-70.6%	0.060%
2/17/2025	Rafferty Asset Management LLC	111,100	$2.76M	0.0%	-40.6%	0.134%
2/17/2025	Raiffeisen Bank International AG	50,000	$1.26M	0.0%	N/A	0.060%
2/17/2025	Redmile Group LLC	1,528,567	$37.91M	2.6%	-5.1%	1.846%
2/17/2025	Point72 Asia Singapore Pte. Ltd.	7,708	$0.19M	0.1%	N/A	0.009%
2/17/2025	Point72 Asset Management L.P.	193,356	$4.80M	0.0%	N/A	0.233%
2/17/2025	Polar Asset Management Partners Inc.	208,255	$5.17M	0.1%	+901.2%	0.251%
2/17/2025	ProShare Advisors LLC	25,446	$0.63M	0.0%	+31.7%	0.031%
2/17/2025	Nuveen Asset Management LLC	181,636	$4.51M	0.0%	-1.6%	0.219%
2/17/2025	Millennium Management LLC	75,353	$1.87M	0.0%	-7.8%	0.091%
2/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	162,407	$4.03M	0.0%	+3.9%	0.196%
2/17/2025	Janus Henderson Group PLC	32,501	$0.81M	0.0%	-12.2%	0.039%
2/17/2025	Hudson Bay Capital Management LP	100,000	$2.48M	0.0%	-13.0%	0.121%
2/17/2025	Graham Capital Management L.P.	12,364	$0.31M	0.0%	+18.8%	0.015%
2/17/2025	Farallon Capital Management LLC	8,239,123	$204.33M	1.0%	+0.4%	9.949%
2/17/2025	Deutsche Bank AG	67,508	$1.67M	0.0%	+54.7%	0.082%
2/17/2025	Cresset Asset Management LLC	27,470	$0.68M	0.0%	-27.9%	0.033%
2/17/2025	Crestline Management LP	62,969	$1.56M	0.1%	+261.6%	0.076%
2/17/2025	Casdin Capital LLC	1,250,000	$31M	2.1%	+61.3%	1.509%
2/17/2025	Bank of America Corp DE	136,933	$3.40M	0.0%	-74.6%	0.165%
2/17/2025	Benjamin Edwards Inc.	24,358	$0.60M	0.0%	+49.3%	0.029%
2/17/2025	BNP Paribas Financial Markets	9,552	$0.24M	0.0%	N/A	0.012%
2/17/2025	Algert Global LLC	9,378	$0.23M	0.0%	-78.5%	0.011%
2/17/2025	ARCH Venture Management LLC	4,540,132	$112.60M	48.9%	-6.1%	5.483%
2/14/2025	Gallagher Fiduciary Advisors LLC	9,220	$0.23M	0.0%	N/A	0.011%
2/14/2025	Mercer Global Advisors Inc. ADV	10,821	$0.27M	0.0%	-29.7%	0.013%
2/14/2025	Schonfeld Strategic Advisors LLC	15,531	$0.39M	0.0%	+55.0%	0.019%
2/14/2025	Northern Trust Corp	740,506	$18.37M	0.0%	+7.2%	0.894%
2/14/2025	The Manufacturers Life Insurance Company	143,502	$3.56M	0.0%	-1.6%	0.173%
2/14/2025	Tudor Investment Corp ET AL	16,575	$0.41M	0.0%	-49.5%	0.020%
2/14/2025	Quarry LP	1,500	$37K	0.0%	-75.0%	0.002%
2/14/2025	Susquehanna Fundamental Investments LLC	52,725	$1.31M	0.0%	N/A	0.064%
2/14/2025	Virtus ETF Advisers LLC	2,534	$63K	0.0%	-30.6%	0.003%
2/14/2025	Voya Investment Management LLC	23,015	$0.57M	0.0%	-7.0%	0.028%
2/14/2025	Price T Rowe Associates Inc. MD	1,753,142	$43.48M	0.0%	+18.0%	2.117%
2/14/2025	Hsbc Holdings PLC	26,514	$0.67M	0.0%	+74.6%	0.032%
2/14/2025	Rock Springs Capital Management LP	252,223	$6.26M	0.2%	+0.9%	0.305%
2/14/2025	Stifel Financial Corp	13,662	$0.34M	0.0%	+27.8%	0.016%
2/14/2025	Tower Research Capital LLC TRC	1,372	$34K	0.0%	-79.0%	0.002%
2/14/2025	MetLife Investment Management LLC	46,900	$1.16M	0.0%	+7.7%	0.057%
2/14/2025	Dimensional Fund Advisors LP	1,538,398	$38.16M	0.0%	+24.0%	1.858%
2/14/2025	First Trust Advisors LP	25,595	$0.64M	0.0%	+42.4%	0.031%
2/13/2025	CANADA LIFE ASSURANCE Co	8,533	$0.21M	0.0%	-7.0%	0.010%
2/13/2025	Marshall Wace LLP	55,000	$1.36M	0.0%	N/A	0.066%
2/13/2025	Jump Financial LLC	34,498	$0.86M	0.0%	-20.0%	0.042%
2/13/2025	Guggenheim Capital LLC	35,827	$0.89M	0.0%	-16.0%	0.043%
2/13/2025	Mariner LLC	13,888	$0.34M	0.0%	+9.7%	0.017%
2/13/2025	Barclays PLC	278,019	$6.90M	0.0%	+51.7%	0.336%
2/13/2025	Summit Investment Advisors Inc.	7,999	$0.20M	0.2%	+6.6%	0.010%
2/13/2025	Sterling Capital Management LLC	2,409	$60K	0.0%	+816.0%	0.003%
2/13/2025	Raymond James Financial Inc.	28,328	$0.70M	0.0%	N/A	0.034%
2/13/2025	Martingale Asset Management L P	11,438	$0.28M	0.0%	+8.6%	0.014%
2/13/2025	Renaissance Technologies LLC	22,907	$0.57M	0.0%	N/A	0.028%
2/13/2025	Legal & General Group Plc	73,342	$1.82M	0.0%	-7.7%	0.089%
2/13/2025	Invesco Ltd.	66,265	$1.64M	0.0%	+4.2%	0.080%
2/13/2025	ADAR1 Capital Management LLC	38,312	$0.95M	0.2%	-12.7%	0.046%
2/13/2025	Federated Hermes Inc.	29,709	$0.74M	0.0%	-20.8%	0.036%
2/13/2025	Russell Investments Group Ltd.	176,181	$4.37M	0.0%	-6.2%	0.213%
2/13/2025	Envestnet Asset Management Inc.	30,467	$0.76M	0.0%	+8.2%	0.037%
2/13/2025	Wells Fargo & Company MN	128,002	$3.17M	0.0%	+17.6%	0.155%
2/12/2025	ExodusPoint Capital Management LP	13,359	$0.33M	0.0%	N/A	0.016%
2/12/2025	Cinctive Capital Management LP	65,242	$1.62M	0.1%	N/A	0.079%
2/12/2025	Massachusetts Financial Services Co. MA	56,027	$1.39M	0.0%	-2.9%	0.068%
2/12/2025	Geode Capital Management LLC	1,804,374	$44.76M	0.0%	-0.2%	2.179%
2/12/2025	Franklin Resources Inc.	21,353	$0.53M	0.0%	+42.0%	0.026%
2/12/2025	Alliancebernstein L.P.	212,804	$5.28M	0.0%	+149.4%	0.257%
2/12/2025	Wellington Management Group LLP	35,569	$0.88M	0.0%	-8.8%	0.043%
2/12/2025	CIBC Private Wealth Group LLC	1,981	$53K	0.0%	-15.5%	0.002%
2/12/2025	Norges Bank	18,591	$0.46M	0.0%	N/A	0.022%
2/12/2025	IQ EQ FUND MANAGEMENT IRELAND Ltd	32,198	$0.80M	0.1%	+145.4%	0.039%
2/12/2025	BIT Capital GmbH	35,414	$0.88M	0.1%	N/A	0.043%
2/12/2025	JPMorgan Chase & Co.	513,671	$12.74M	0.0%	-19.6%	0.620%
2/12/2025	Mitsubishi UFJ Asset Management Co. Ltd.	9,613	$0.24M	0.0%	-9.4%	0.012%
2/11/2025	Corebridge Financial Inc.	38,013	$0.94M	0.0%	-7.0%	0.046%
2/11/2025	Vanguard Group Inc.	7,621,989	$189.03M	0.0%	-2.8%	9.204%
2/11/2025	LPL Financial LLC	27,698	$0.69M	0.0%	+5.6%	0.033%
2/11/2025	KLP Kapitalforvaltning AS	13,400	$0.33M	0.0%	N/A	0.016%
2/11/2025	American Century Companies Inc.	135,380	$3.36M	0.0%	+13.2%	0.163%
2/11/2025	Yiheng Capital Management L.P.	426,102	$10.57M	0.4%	-44.2%	0.515%
2/11/2025	Teacher Retirement System of Texas	20,767	$0.52M	0.0%	+18.4%	0.025%
2/11/2025	Intech Investment Management LLC	29,401	$0.73M	0.0%	+40.7%	0.036%
2/10/2025	Nikko Asset Management Americas Inc.	3,957,611	$98.11M	1.1%	+11.4%	4.779%
2/10/2025	Horizon Kinetics Asset Management LLC	9,597	$0.24M	0.0%	+4.4%	0.012%
2/10/2025	Swiss National Bank	137,800	$3.42M	0.0%	+0.8%	0.166%
2/7/2025	Wealthfront Advisers LLC	1,637	$41K	0.0%	N/A	0.002%
2/7/2025	AlphaQuest LLC	2,610	$65K	0.0%	-92.8%	0.003%
2/6/2025	Vestmark Advisory Solutions Inc.	173,152	$4.48M	0.2%	+29.3%	0.209%
2/6/2025	Raymond James Financial Inc.	28,328	$0.70M	0.0%	N/A	0.034%
2/6/2025	Proficio Capital Partners LLC	16,368	$0.41M	0.0%	N/A	0.020%
2/6/2025	Atria Investments Inc	9,562	$0.24M	0.0%	+17.1%	0.012%

Data available starting January 2016

See Full Table

Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 for the treatment of sickle cell disease or beta-thalassemia; and BEAM-302, a liver-targeting LNP formulation to treat severe alpha-1 antitrypsin deficiency; BEAM-201, an anti-CD7 CAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of refractory T-cell acute lymphoblastic leukemia/T cell lymphoblastic lymphoma; and BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease 1a. The company has research collaboration agreement with Pfizer Inc., focus on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Apellis Pharmaceuticals to conduct preclinical research on target specific genes within the complement system in various organs, including the eye, liver, and brain; Verve Therapeutics, Inc., for cardiovascular disease treatments; Sana Biotechnology, Inc., to research, develop, and commercialize rights to CRISPR Cas12b for cell therapy programs; and Orbital Therapeutics design RNA for the prevention, treatment or diagnosis of human disease. Beam Therapeutics Inc. was incorporated in 2017 and is based in Cambridge, Massachusetts.

Today's Range

Now: $24.23

$23.94

$25.81

50 Day Range

MA: $27.09

$23.30

$34.16

52 Week Range

Now: $24.23

$20.84

$36.75

Volume

2,166,679 shs

Average Volume

1,208,302 shs

Market Capitalization

$2.42 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.91

Who are the company insiders with the largest holdings of Beam Therapeutics?: Beam Therapeutics' top insider investors include:
Fmr Llc (Insider)
John M Evans (CEO)
Giuseppe Ciaramella (President)
Giuseppe Ciaramella (Insider)
Christine Bellon (Insider)
Amy Simon (Insider)
Terry-Ann Burrell (CFO)
Bethany J Cavanagh (SVP)
Learn More about top insider investors at Beam Therapeutics.
Who are the major institutional investors of Beam Therapeutics?: Beam Therapeutics' top institutional shareholders include:
Farallon Capital Management LLC — 9.95%
Vanguard Group Inc. — 9.20%
ARK Investment Management LLC — 8.54%
ARCH Venture Management LLC — 5.48%
Sumitomo Mitsui Trust Group Inc. — 4.78%
Nikko Asset Management Americas Inc. — 4.78%
Learn More about top institutional investors of Beam Therapeutics stock.
Which institutional investors are selling Beam Therapeutics stock?: During the previous quarter, BEAM stock was sold by these institutional investors:
Bank of America Corp DE
Yiheng Capital Management L.P.
ARCH Venture Management LLC
Vanguard Group Inc.
JPMorgan Chase & Co.
Tang Capital Management LLC
Redmile Group LLC
Rafferty Asset Management LLC
In the last year, company insiders that have sold Beam Therapeutics company stock include:
Fmr Llc (Insider)
John M Evans (CEO)
Giuseppe Ciaramella (President)
Giuseppe Ciaramella (Insider)
Christine Bellon (Insider)
Amy Simon (Insider)
Learn More investors selling Beam Therapeutics stock.
Which institutional investors are buying Beam Therapeutics stock?: In the previous quarter, BEAM stock was bought by institutional investors including:
ARK Investment Management LLC
Casdin Capital LLC
Nikko Asset Management Americas Inc.
Sumitomo Mitsui Trust Group Inc.
Dimensional Fund Advisors LP
Woodline Partners LP
Price T Rowe Associates Inc. MD
Point72 Asset Management L.P.